GPR141 and breast carcinoma: GPR141 amplification was observed in different breast cancer sub-types, with high alteration frequency observed in breast invasive mixed mucinous carcinoma (4% altered out of 25 cases) and breast invasive ductal carcinoma (2.23% in 1660 cases) (Figure 1B).